Head-To-Head Analysis: Envoy Medical (COCH) and The Competition

Envoy Medical (NASDAQ:COCH – Get Free Report) is one of 511 publicly-traded companies in the “Healthcare Equipment & Supplies” industry, but how does it contrast to its rivals? We will compare Envoy Medical to similar companies based on the strength of its dividends, earnings, risk, profitability, valuation, institutional ownership and analyst recommendations.

Profitability

This table compares Envoy Medical and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Envoy Medical -9,026.41% -5,250.23% -112.19%
Envoy Medical Competitors -300.62% -179.55% -22.71%

Analyst Recommendations

This is a breakdown of current recommendations for Envoy Medical and its rivals, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Envoy Medical 1 1 2 0 2.25
Envoy Medical Competitors 4309 10596 18377 837 2.46

Envoy Medical presently has a consensus target price of $21.00, indicating a potential upside of 211.57%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 21.19%. Given Envoy Medical’s higher possible upside, equities analysts clearly believe Envoy Medical is more favorable than its rivals.

Volatility and Risk

Envoy Medical has a beta of 2.03, meaning that its share price is 103% more volatile than the S&P 500. Comparatively, Envoy Medical’s rivals have a beta of 5.41, meaning that their average share price is 441% more volatile than the S&P 500.

Insider & Institutional Ownership

8.6% of Envoy Medical shares are held by institutional investors. Comparatively, 40.5% of shares of all “Healthcare Equipment & Supplies” companies are held by institutional investors. 7.2% of Envoy Medical shares are held by company insiders. Comparatively, 14.9% of shares of all “Healthcare Equipment & Supplies” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Valuation and Earnings

This table compares Envoy Medical and its rivals revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Envoy Medical $240,000.00 -$23.76 million -1.47
Envoy Medical Competitors $1.89 billion $136.85 million 5.73

Envoy Medical’s rivals have higher revenue and earnings than Envoy Medical. Envoy Medical is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Summary

Envoy Medical rivals beat Envoy Medical on 12 of the 13 factors compared.

About Envoy Medical

(Get Free Report)

Envoy Medical is a medical technology company focused on developing implantable hearing devices. Based in White Bear Lake, Minnesota, the company was founded in 1995 and specializes in technologies intended to help people with hearing loss. Its product portfolio includes the Esteem Active Middle Ear Implant, an FDA-approved fully implanted hearing device for adults with moderate to severe sensorineural hearing loss. The company is also developing Acclaim, a fully implanted cochlear implant designed for people with severe to profound hearing loss.

Receive News & Ratings for Envoy Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envoy Medical and related companies with MarketBeat.com's FREE daily email newsletter.